Evidence map›Paper›PMID 33323426›Full record

ArticleBMJ open2020

Zika virus infection in pregnancy: a protocol for the joint analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortia.

A E Ades, Elizabeth B Brickley, Neal Alexander, David Brown, Thomas Jaenisch, Demócrito de Barros Miranda-Filho, Moritz Pohl, Kerstin D Rosenberger, Antoni Soriano-Arandes, Claire Thorne and 27 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 17 countries.

A E AdesDepartment of Population Health Sciences, University of Bristol Medical School, Bristol, UK.
Elizabeth B BrickleyDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Neal AlexanderDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
David BrownFlavivirus Reference Laboratory, Fundacão Oswaldo Cruz, Rio de Janeiro, Brazil.
Thomas JaenischDepartment of Infectious Diseases, Section Clinical Tropical Medicine, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Demócrito de Barros Miranda-FilhoUniversidade Federal de Pernambuco, Recife, Brazil.
Moritz PohlInstitute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Kerstin D RosenbergerDepartment of Infectious Diseases, Section Clinical Tropical Medicine, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Antoni Soriano-ArandesPaediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Barcelona, Spain.ORCID 0000-0001-9613-7228
Claire ThorneGreat Ormond Street Institute of Child Health, University College London, London, UK claire.thorne@ucl.ac.uk.ORCID 0000-0003-0389-1956
Ricardo Arraes de Alencar XimenesUniversidade Federal de Pernambuco, Recife, Brazil.
Thalia Velho Barreto de AraújoUniversidade Federal de Pernambuco, Recife, Brazil.
Vivian I Avelino-SilvaDepartment of Infectious and Parasitic Diseases, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, São Paulo, Brazil.
Sarah Esperanza Bethencourt CastilloFacultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela.
Victor Hugo Borja AburtoMexican Institute of Social Security, Mexico City, Mexico.
Patrícia BrasilInstituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil.
Celia D C ChristieDepartment of Child and Adolescent Health, University of the West Indies at Mona, Kingston, Jamaica.
Wayner Vieira de SouzaInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brazil.
Jose Eduardo Gotuzzo HInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Bruno HoenINSERM Centre d'Investigation Clinique 1424, Centre Hospitalier Universitaire de Pointe-à-Pitre, Guadeloupe, France.
Marion KoopmansDepartment of Viroscience, Erasmus Universiteit Rotterdam, Rotterdam, Zuid-Holland, The Netherlands.
Celina Maria Turchi MartelliInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brazil.
Mauro Martins TeixeiraUniversidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Ernesto T A MarquesInstituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brazil.
Maria Consuelo MirandaUniversidad Industrial de Santander, Bucaramanga, Colombia.
Ulisses Ramos MontarroyosUniversidade de Pernambuco, Recife, Brazil.
Maria Elisabeth MoreiraFigueira National Institute for Women's, Children's and Adolescents Health, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil.
J Glenn MorrisEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Barry RockxDepartment of Viroscience, Erasmus Universiteit Rotterdam, Rotterdam, Zuid-Holland, The Netherlands.
Paola Mariela Saba VillarroelCentro Nacional de Enfermedades Tropicales, Santa Cruz de la Sierra, Santa Cruz de la Sierra, Bolivia.
Carmen Soria SegarraUniversidad Católica de Santiago de Guayaquil, Guayaquil, Guayas, Ecuador.
Adriana TamiFacultad de Ciencias de la Salud, Universidad de Carabobo, Valencia, Venezuela.ORCID 0000-0002-1918-9144
Marília Dalva TurchiInstitute of Tropical Pathology and Public Health, Federal University of Goias, Goiânia, Brazil.
Carlo GiaquintoDepartment of Woman's and Child's Health, Università degli Studi di Padova, Padova, Italy.
Xavier de LamballerieAix-Marseille Université Institut Universitaire de Technologie d'Aix-en-Provence, Aix-en-Provence, Provence-Alpes-Côte d'Azur, France.
Annelies Wilder-SmithDepartment of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
EC Zika Consortia Vertical Transmission Study Group
Fundação Oswaldo Cruz · BRHeidelberg University · DEUniversidade Federal de Pernambuco · BRErasmus University Rotterdam · NLLondon School of Hygiene & Tropical Medicine · GBAix-Marseille Université · FRCentro Nacional de Enfermedades Tropicales · BOGreat Ormond Street Hospital · GBIndustrial University of Santander · COInserm · FRInstituto Evandro Chagas · BRMexican Social Security Institute · MXUmeå University · SEUniversidad Católica de Santiago de Guayaquil · ECUniversidade de Pernambuco · BRUniversidade de São Paulo · BRUniversidade Federal de Goiás · BRUniversidade Federal de Minas Gerais · BRUniversidad Peruana Cayetano Heredia · PEUniversity Medical Center Groningen · NL

Funding

Medical Research Council MC_U145079307Medical Research Council MR/R010161/1Wellcome TrustWellcome Trust 205377/Z/16/Z
6 · The paper itself

Abstract

introductionZika virus (ZIKV) infection in pregnancy has been associated with microcephaly and severe neurological damage to the fetus. Our aim is to document the risks of adverse pregnancy and birth outcomes and the prevalence of laboratory markers of congenital infection in deliveries to women experiencing ZIKV infection during pregnancy, using data from European Commission-funded prospective cohort studies in 20 centres in 11 countries across Latin America and the Caribbean. METHODS AND ANALYSIS: We will carry out a centre-by-centre analysis of the risks of adverse pregnancy and birth outcomes, comparing women with confirmed and suspected ZIKV infection in pregnancy to those with no evidence of infection in pregnancy. We will document the proportion of deliveries in which laboratory markers of congenital infection were present. Finally, we will investigate the associations of trimester of maternal infection in pregnancy, presence or absence of maternal symptoms of acute ZIKV infection and previous flavivirus infections with adverse outcomes and with markers of congenital infection. Centre-specific estimates will be pooled using a two-stage approach. ETHICS AND DISSEMINATION: Ethical approval was obtained at each centre. Findings will be presented at international conferences and published in peer-reviewed open access journals and discussed with local public health officials and representatives of the national Ministries of Health, Pan American Health Organization and WHO involved with ZIKV prevention and control activities.

Indexed as

Pregnancy Complications, InfectiousZika VirusZika Virus InfectionCaribbean RegionCohort StudiesFemaleHumansLatin AmericaPregnancyProspective StudiesRiskepidemiologypaediatric infectious disease & immunisationpublic health

Identifiers

PMID33323426
PMCPMC7745317
OpenAlexW3107285918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.